A plea for a combined medicosurgical treatment of ulcerative colitis has been made. While considerable advances in therapy have improved the results ofmedical treatment in the last 20 years increasing knowledge ofthe natural history and prognosis of ulcerative colitis has shown that proctocolectomy has been increasingly required in severe colitic attacks, in elderly subjects and in patients with total colonic involvement.
Summary.
A plea for a combined medicosurgical treatment of ulcerative colitis has been made. While considerable advances in therapy have improved the results ofmedical treatment in the last 20 years increasing knowledge ofthe natural history and prognosis of ulcerative colitis has shown that proctocolectomy has been increasingly required in severe colitic attacks, in elderly subjects and in patients with total colonic involvement. U LeE RAT I V E colitis is best managed by a combined medicosurgical approach of a vigilant general practitioner, a patient persevering physician and by a surgeon interested in the disease and skilled in the difficult colonic surgery which colectomy in the acutely ill colitic patient may demand. It has been suggested that because of the frequent psychosomatic problems in these patients a psychiatrist should complete the team, a method employed recently in a Michigan clinic (McDermott et al., 1964) .
Medical treatment
Medical treatment should be governed by three principles firstly, to terminate the colitic attack as rapidly as possible, secondly by maintenance treatment to prevent relapse or complications and thirdly to recognise timeously that medical treatment has failed and to refer the patient for urgent or elective surgery.
Treatment of the acute attack. Rest. Any colitic attack benefits by bed rest and any patient with severe diarrhoea, copious bloody stools, fever, anaemia and weight loss should be admitted to hospital.
Rest can be facilitated by the administration of sedative and tranquillising drugs, such as phenobarbitone, amylobarbitone, meprobamate, chlordiazepoxide or diazepam in adequate dosage. Hypnotics such as chloral hydrate, amylobarbitone, pentobarbitone or glutethimide are frequently required.
Colonic rest. In the severely ill patient with continuous diarrhoea the colon may be rested by the complete withdrawal of oral feeding and maintenance by parenteral fluids. Later a fluid diet and finally a low-residue highprotein diet is given.
Secondly, a wide variety of antispasmodic and antidiarrhoeal drugs can be given in doses sufficient to produce mild side effects. and will often control both diarrhoea and cramping abdominal pain. Their use is contraindicated in patients with glaucoma, dysuria and if given to severely ill patients may induce intestinal atony simulating toxic megacolon.
Belladonna derivatives are often used either as the tincture or as a sustained release tablet (Belladenal retard-Donnatal). Synthetic anticholinergic drugs such as propantheline bromide or poldine methylmethosulphate can be given.
For profuse diarrhoea the use of opiates is justified provided that it is realised that these drugs have addictive properties, may mask perforation, increase abdominal distension and therefore should only be prescribed for short periods. Codeine phosphate tablets, tincture of opium or tincture of chloroform and morphia can be used. Lomotil is a useful proprietary preparation combining a codein derivative diphenoxylate hydrochloride with atropine sulphate.
Thickening of the stools with such bulk forming agents as psyllium seeds or methylcellulose will often lessen diarrhoea while some patients with proctocolitis are in fact, constipated and require mild laxatives such as milk of magnesia or standardised senna.
Maintenance of nutrition and of fluid and electrolyte balance. In severe attacks gross dehydration and profound electrolyte and metabolic imbalance may develop making it vital that such cases be managed in hospital where adequate biochemical facilities are available. A hyponatraemic, hypokalaemic acidosis often develops necessitating correction by intravenous infusion. Potassium supplements may need to be massive and of the order of 80 m.Eq. daily. Subsequently additional salt and potassium can be given orally as enteric coated, effervescent or slow release tablets. Vitamin replacements are necessary in many severely ill and debilitated patients, and intravenous protein replacement may have to be attempted in critically ill patients using whole blood, plasma or protein hydrolysates. Claims have been made that anabolic steroids orally or intramuscularly may accelerate weight gain and improve appetite in colitic patients (Kasich, 1963) .
Correction of anaemia. Anaemia commonly needs correction both in the acute and chronic phase of the disease either by blood transfusion or by iron therapy. Coli tic patients are often intolerant of iron making it necessary to use an enteric coated or sustained release tablet or to give iron intravenously or intramuscularly.
Antibiotics. Antibiotics used discriminately and given parenterally may markedly improve the febrile toxic colitic patient but given orally may worsen diarrhoea and predispose to secondary infection with monilial organisms. A combination of penicillin and streptomycin is best tried initially or alternatively intramuscular tetracycline, chloramphenicol or ampicillin can be administered in short courses. Neomycin or succinylsulphathiazole given orally will often produce improvement and is useful pre-operatively.
Diet. Rapid weight loss, vitamin deficiencies and hypoproteinaemia commonly accompany acute and chronic attacks of ulcerative colitis and make it vital that the patient eats as much of a high-protein low-residue diet as his condition allows.
Milk restriction has been advocated in ulcerative colitis because of possible allergy to milk proteins (Truelove, 1961) and some patients may have alactasia and are unable to digest lactose. in a controlled trial of a milk 134 free diet reported twice as many prolonged symptomatic remissions and fewer severe relapses in a group of 26 colitic patients on a milk-free diet compared with 24 colitic patients on a normal diet. The differences between the groups treated were only marginally significant and a larger series will be required to prove the value of the diet. Wright and Truelove suggest that approximately 1 in 5 patients with ulcerative coltis will benefit from milk restriction particularly in first attacks of the disease. No correlation was found between high titres of antibodies to milk and response to a milk free diet making it impossible to select patients likely to respond to milk restriction. The diet cannot routinely be advocated but is well worth a trial in selected patients not responding to other measures.
Psychotherapy. Psychotherapy, first advocated by Murray in 1930, has proved to be one of the most controversial aspects of the treatment of ulcerative colitis. While excellent results were obtained by Paulley (1950) , Groen (1961) and Grace and Graham (1952) other gastroenterologists report serious colitic complications during formal psychotherapy and only 1 of 12 patients so treated benefitted from it (Crohn & Yarnis, 1951) .
A constructive patient-physician relationship should be established and common sense psychotherapy given for the patient's personal and environmental difficulties. It is vital that psychotherapy be practised in close association with, or preferably by, a physician skilled in the management of ulcerative colitis. There is certainly no place for psychotherapy in isolation.
Sulphasalazine. Sulphasalazine (Salazopyrin) was first used successfully in the treatment of ulcerative colitis by Svartz in 1942 and a number of uncontrolled and controlled trials in subsequent years have confirmed its value (Svartz, 1956 (Svartz, , 1961 Morrison, 1953; Moertal & Bargen, 1959; Watkinson, , 1962 Watkinson, , 1968 Truelove, et al., 1962) .
Plain tablets containing 0.5g. of sulphasalazine should be given initially, reserving enteric coated tablets for patients exhibiting gastrointestinal intolerance to the uncoated tablets. Usually 2 to 4 tablets 4 times daily are used depending on the tolerance of the patient. Nausea, vomiting and headache may occur in about 20 per cent of those treated and can usually be controlled by substituting the enteric coated tablet in the same dosage. Rarely drug fever, skin rashes, leucopenia, haemolytic anaemia or even agranulocytosis may complicate therapy and demand immediate cessation of the drug. Eight hundred and sixty-one colitic patients treated in Sweden, America and England with sulphasalazine between 1956 and 1964 showed remission rates varying between 47 and 77 per cent (Watkinson, 1968) , and a controlled trial by Dick and his colleagues in 1964firmly established the value of the drug. In that trial twice as many patients receiving sulphasalazine went into remissions as did controls, namely 78 per cent as compared with 35 per cent.
An analogue of sulphasalazine, salicylazosulfadimidine was submitted to trials with conflicting results. Most authors found it to be less effective and more toxic than sulphasalazine Watkinson 1968 ). This compound has now been withdrawn.
Sulphasalazine incorporated into a suppository containing l g. of the drug has recently been shown by a controlled trial to exert a beneficial topical action when inserted nightly in patients with distal proctocolitis and was without side effects (Watkinson, 1968) .
Systemic corticosteroids. In the last 15 years the value of corticosteroids in colitis whether used topically or systemically, has been proven by a number of controlled trials. They are capable on occasions of producing remarkable remissions but, at other times fail to control the disease. The indications and value of steroid treatment in colitis have been reviewed elsewhere (Watkinson, 1966) .
Steroids are indicated in any severe colitic attack or relapse failing to respond to simple measures or sulphasalazine and particularly when associated with systemic colitic complications likely to respond to steroids. They should be used with caution in patients with established electrolyte disturbances, malnutrition, marked abdominal distension or massive rectal bleeding or in the presence of coincident disease known to be worsened by steroids, such as diabetes, tuberculosis or peptic ulcer. Steroids are contraindicated if perforation or peritonitis is suspected, if a toxic megacolon has developed or if severe perianal disease is present.
Dosage and rate of administration will vary with the severity of the attack. In fulminating disease ACTH administered initially intravenously and later intramuscularly in a dosage of 80 to 120 units daily will produce remissions in about two thirds of those treated (Truelove & Witts, 1959; . Cortisone in doses of 150 to 300 mg. daily given orally produces fewer remissions than ACTH but still in the significant proportion of 2 out of 5 of those so treated (Truelove & Witts, 1955; Watkinson 1966) . For milder attacks in ambulatory patients prednisone tablets 20 to 60 mg. daily are used initially with a reduction to 10 to 15 mg. daily as improvement occurs.
Steroids were shown in controlled trials to halve the mortality and recourse to surgery. They did not predispose to perforation, though suppurative perianal complications were more common in the steroid treated group, making it desirable to combine steroid treatment with either sulphasalazine or a parenterally administered antibiotic (Truelove & Witts, 1955 , de Dombal et al., 1965 .
Systemic steroids have therefore emerged as a significant adjuvant to the treatment of colitis.
Topical corticosteroids. A series of controlled trials has established the value of topical steroids in ulcerative colitis since this method of administration was first advocated by Truelove in 1956 . With most types of topical treatment side effects are minimal and it is possible to obtain much higher concentrations of steroid locally than could be achieved by systemic therapy. However, the method may prove cumbersome and unacceptable to many patients, while those with profuse diarrhoea may be unable to retain the enemata adequately.
Freshly prepared hydrocortisone hemisuccinate sodium can be administered by rectal drip in doses of 100 mg. and achieves the deepest penetration into the colon. It exerts a beneficial effect in 52 to 69 per cent of those treated (Truelove, 1958; Patterson et al., 1963; . The stability of prednisolone-21-phosphate enabled it to be administered as a retention enema to patients with distal proctocolitis and remission rates of 75 to 88 per cent were claimed (Matts, 1960; Matts & Gaskell, 1961; . While retention enemata of betamethasone, a steroid 50 times more potent than hydrocortisone, induced remissions in four fifths of the patients treated its use was complicated by frequent and severe side effects and compelled the manufacturers to withdraw this type of enema (Matts, 1962) . The new steroid betamethasone -17-valerate (Betnovate) which has enhanced topical and reduced systemic effects is now under evaluation in enema form. Preliminary trials suggest that it may be of some value (Gill, et al., 1965) .
Steroids can be most conveniently administered topically as suppositories containing small doses of prednisolone. This is of proven value in patients with distal proctocolitis (Truelove, 1959; Patterson et al., 1963; Lennard-Jones et al., 1962) .
Topical steroid treatment therefore emerges as a useful form of therapy most applicable to mild cases of colitis with distal disease. The value of topical treatment is enhanced by simultaneous administration of steroids orally Truelove et al., 1962) .
Immunosuppressive agents. Improvement in autoimmune diseases treated with immunosuppressive agents lead Bean (1960) to advocate their use in ulcerative colitis. While these drugs might suppress immune reactions they can produce marrow depression with resulting anaemia, leucopenia and thrombocytopema which certainly will not aid the physician treating a condition with established infective and haemorrhagic features.
Australian workers (Bean, 1960 (Bean, , 1962 MacKay et. al, 1966) , have used drugs like azathioprine, 6-mercaptopurine or busulphan to treat 14 colitic patients 12 of whom showed immediate and 11 sustained improvement, though eventually 3 came to colectomy and there was one death. The experience of other workers was less favourable: only one of 10 patients treated showing a sustained improvement. Marrow depression was sufficiently common to lead them to abandon this form of therapy (Bowen et al., 1966; Kirsner, 1967) . The use of these agents cannot be 136 advocated at present until further assessment by research centres specialising in handling colitic patients has been made.
Maintenance treatment. Having controlled the acute attack the physician should next attempt to prevent relapses or complications.
Sulphasa1azine in doses of 2g. daily has been reported to keep between half and three quarters of a large group of colitic patients in good health for periods of 1 to 5 years and to be relatively free from side effects (Svartz, 1956; Moertal & Bargen, 1959; Watkinson, 1962) . In 1965 a controlled trial proved that small doses of sulphasalazine were capable of preventing relapses in a significant proportion of those treated .
In using steroids to prevent colitic relapse two courses are open to the physician. He may give sufficiently large doses to suppress the disease, accepting frequent side effects, or alternatively he may give smaller doses, accepting an appreciable relapse rate and recourse to surgery (Watkinson, 1966) .
While large maintenance doses of cortisone or ACTH given by the Chicago workers kept two thirds of their 340 colitic patients in remission or good health for long periods with a low mortality and little recourse to surgery, side effects developed in 85 per cent of those treated and 7 deaths were attributed to steroid therapy itself (Spencer et 01., 1962) . However, the authors felt good control of the disease was adequate compensation for the side effects encountered.
There is no evidence to suggest that small doses of steroids prevent colitic relapses. One controlled trial (Truelove & Witts, 1959) , failed to show any difference in relapse rates in two groups of colitic patients followed for a year receiving either 50 mg. of cortisone daily or identical dummy tablets. In a second controlled trial two groups of colitic patients in remission received either 15 mg. of prednisone daily or identical inert tablets, relapse rates being similar in both groups after 6 months.
No controlled evidence therefore exists to show that prolonged treatment with small or large doses of steroids materially influences the natural history of colitis.
Modifications of medical treatment in relation to severity, extent, clinical pattern and complicationsof colitis. Medical treatment will have to be modified appreciably by the severity of the attack, extent of colonic involvement and the presence of colonic or systemic complications.
Fulminating colitic attacks carry a depressingly high mortality of between 11 and 50 per cent (Lennard-Jones & Vivian, 1960; Goulston et al., 1960; Goligher et al., 1967) and demand prompt diagnosis, vigorous medical treatment and early surgery, particularly in elderly subjects, unless a prompt response to medical treatment occurs. In chronic attacks the physician has more time to apply the full therapeutic regime advised.
Extent of the disease modifies medical management. Patients with proctocolitis are seldom ill and often constipated. Bulk forming laxatives often improve them and it is in this group that topical treatment with salazopyrin and steroids are most effective. It should be remembered that in at least one third of these patients the disease may spread proximally bringing the complications of more extensive disease. Patients with segmental colitis pose problems in diagnosis as the distinction from granulomatous or ischaemic colitis may be difficult. Patients with total colonic involvement are prone to relapses, have a considerable cancer risk and are least likely to respond to medical treatment so that in them a strong case can be made for prophylactic proctocolectomy.
The duration of the illness materially worsens the prognosis and increases the cancer risk thus swaying the physician towards surgery. The age of the patient poses two problems. Children afflicted by the Table I 
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The Management of Ulcerative Colitis disease may show physical retardation and with long histories are still prone to develop carcinomata. Elderly subjects show an appreciably higher mortality in acute colitic attacks and relapses. In both of these age groups surgery should be increasingly employed.
Serious colonic complications are unlikely to be modified by medical treatment. Rarely skin complications and arthritis can prove refractory to medical treatment and colectomy will usually cure these. Iritis, liver disease and sacroileitis are less likely to be controlled by colectomy and may be indications for continuing medical treatment (Watkinson, 1968 ).
Surgical treatment
It will be apparent from the foregoing paragraphs that conservative management has nowadays far more to offer the colitic patient than was the case even as little as 10 years ago; and certainly the majority of patients with mild or distal colitis can be satisfactorily managed on such a regime. However, in a substantial number of cases medical treatment fails to control the patient's colitis; and in such instances surgical measures become necessary.
Perhaps the most difficult problem in present day management of patients with ulcerative colitis is the selection of patients for radical surgery. For, whilst timely surgical intervention carries a low mortality and an excellent prognosis, surgical intervention which comes too late can do little to alleviate an already dangerous situation (de Dombal et al., 1965 a, b; Watts et al., 1966 a, b;  Goligher et al., 1967) . In the following paragraphs we shall define the indications for surgery in ulcerative colitis under four categories, according to the urgency of operative intervention (see also Table I ).
Emergency operation. An emergency operation for ulcerative colitis is nearly always carried out during a severe attack (defined according to the criteria of Truelove & Witts, 1955) , when it may be occasionally required to deal with certain lethal complications such as perforation, acute colonic dilatation, or rarely massive haemorrhage.
Perforation. Sometimes this complication manifests itself by the sudden development of unequivocal local abdominal symptoms and signs-such as severe abdominal pain, generalised guarding and rigidity, and evidence on radiological examination of free gas under the diaphragm. Under these circumstances conservative management should be abandoned forthwith, for the mortality of patients managed conservatively in this situation approaches 100 per cent (Jankelson et al., 1946) ; whereas emergency colectomy offers a chance of survival to nearly four fifths of such patients (de Dombal et al., 1965a) .
It is however, important to emphasize that this 'classical' presentation of colitic perforation does not often occur-perhaps because most severe attacks are treated with large doses of steroids which in themselves may tend to mask such signs as guarding and tenderness in the abdomen (Graham et al., 1968) . In our own series of patients we completely failed to diagnose prior to operation fully half of the perforations which had occurred; and our own experience has been that the commonest way for such an intra-abdominal catastrophe to declare itself has been by a sudden deterioration in the patient's general condition.
Such deterioration in the general condition of the patient during a severe attack, despite intensive conservative measures, clearly calls for emergency laparotomy; for fully twofifths of such patients will have perforated, and it is often impossible to diagnose this condition on clinical grounds alone.
Acute dilatation. For the past decade there has been considerable controversy concerning the treatment of this complication (Roth et al., 138 1959; Pesking & Davis, 1960; Sampson & Walker, 1964) . Our own feeling is that the mortality after emergency laparotomy (15%) is substantially less than that of continued conservative management (30%). Hence this complication should be regularly sought for during severe attacks of ulcerative colitis by daily X-ray examination; and when found is an indication for immediate colectomy or proctocolectomy.
Massive haemorrhage. This complication is often cited as an indication for emergency operation; but our own experience confirms that of Edwards and Truelove (1964) , that major bleeding from the large intestine in severe attacks of colitis almost invariably responds to conservative measures as outlined above. Only very exceptionally is radical surgery called for as an emergency measure on account of continued severe bleeding.
Urgent operation. The one over-riding indication for urgent surgery in dealing with ulcerative colitis is the failure of conservative management during severe or moderately severe attacks of the disease to control the patient's symptoms. Unfortunately, however, whilst most authorities would agree with this overall proposition, the decision as to how long to persist with intensive medical treatment before failure is acknowledged by the physician is a difficult and a controversial one.
Periods ranging from 4 to 14 days have been suggested by different authorities in this country (Brooke, 1956; Lennard-Jones & Wolfe, 1960; Goligher, 1961) . Up to 1963 we ourselves had accepted a 'trial period' of some 10 days for medical measures during severe attacks following which operation was performed if there was no unequivocal evidence of commencing remission. However, experience in the last few years with a much shorter 'trial period' of intensive medical treatment has shown a dramatic reduction in the mortality in our own patients during severe attacks (Table II) . As we have emphasized (Goligher et al., 1967) , there are possible fallacies in comparing our own results during two different time periods; but nevertheless we now feel that the period of medical trial should be normally nearer to 4 than to 14 days. This applies particularly in the case of the elderly patient, for whom the period of Goligher et al. (1967) preliminary conservative management during a severe attack of ulcerative colitis should probably not exceed 4 to 5 days. If at the end of this time no obvious improvement has occurred, the patient should be brought to urgent operation. One criticism which can be levelled at this scheme of management is that occasionally patients will come to proctocolectomy who might otherwise have gone into remission on more prolonged conservative management. However, recent studies of serum protein levels during severe attacks of ulcerative colitis show that the prognosis of a severe attack of ulcerative colitis can often be determined during the first few days (de Dombal, 1968) . If this work can be confirmed and easily reproduced in other centres such studies may prove a useful guide to the clinician.
Elective operation. Chronic invalidism. In many cases the indication for surgery on these grounds is only too obvious, as when a patient with a history of colitis for several years presents in a state of extreme emaciation, with gross extensive changes in the large bowel on sigmoidoscope and radiological examination, and often with multiple complications of the disease. Even the most conservatively minded physician would nowadays admit that the only chance of restoring such an individual to a reasonable state of health and a useful existence lies with surgery.
The seriousness of such a decision for the patient should certainly not be underrated; since, when first contemplated by a lay person-particularly a young woman-an ileostomy must seem a revoltingly unnatural arrangement and one which is likely to put an end to all romantic aspirations. Without doubt the best way to overcome such misgivings is for the patient to have a heart to heart talk with a well adjusted ileostomist from the same walk of life. It is very seldom that this tactic is unsuccessful in securing consent; (and, far more important, in reassuring the prospective surgical patient).
Risk of cancer. The risk of malignant degeneration in patients with ulcerative colitis is almost entirely confined to patients with total or near-total colitis of at least 8 to 10 years duration. The only really satisfactory way of dealing with such cancer is to anticipate its development in predisposed individuals by means of prophylactic proctocolectomy. As our own studies have shown, (de Dombal et al., 1966) the risk of carcinomatous change in predisposed individuals with total involvement may reach as high as 40 per cent after 25 years and nearly 60 per cent after 30 years. Compared with these risks, the risk to life of 3 or 4 per cent by elective surgery seems low indeed.
Local complications. Occasionally, patients will present with a frankly invasive carcinoma of the colon or rectum, and in these circumstances exploratory laporotomy and colectomy are usually indicated. In this latter context it must be emphasized that we believe operation to be indicated whenever stricture develops in connection with ulcerative colitis; for it is impossible to be certain that such a stricture does not harbour malignancy. By contrast the occurence of multiple inflammatory polyps in connection with ulcerative colitis is not thought to carry any intrinsic risk of carcinogenesis (de Dombal et al., 1966) . Ano-rectal abscesses, fistulas and fissures are only rarely indications for radical surgery for they often show a remarkable degree of spontaneous improvement as the patient's colitis undergoes remission. There is however, one exception to this general rule and that is the presence of a recto-vaginal fistula. In our own group of patients we have not observed a single instance of spontaneous healing of such fistulas, and hence the development of this particular lesion is a firm indication for radical surgery.
Systemic complications. Remote .. ,.. ileostomy is well accepted by the vast majority of such children and seems to cause them amazingly little psychological upset.
Prophylactic operation. Our own follow-up studies (Watts et al., 1966 a, b) and those from Oxford of Edwards and Truelove (1963) have indicated two groups of patients who are particularly at risk from ulcerative cohtis, namely those with extensive disease, and elderly patients. We believe the risks from continued conservative management to be so great in these patients as to warrant serious consideration of prophylactic surgery.
Total involvement. The patients most likely to develop severe attacks, resulting in urgent or emergency surgery with all the risks that this entails, are those with total or near-total involvement of the large bowel. The mortality from ulcerative colitis in such patients is no less than 2.7 per cent per annum, (Watts et al., 1966 b) . Of course there is some risk attached even to elective proctocolectomy; but nevertheless after 3 or 4 years the risks of conservative management in patients with total involvement clearly outweigh the total risks of radical operation and any post-operative complications. When the long term view over a period of 20 or 25 years is taken into account (Fig. 1) , the mortality of surgery and its complications pales into insignificance when compared with the cumulative mortality in patients with total involvement treated conservatively. surgery is recommended solely for this reason several important points should be noted. First, it is vital to be certain that the troublesome lesion is indeed a systemic complication of ulcerative colitis and not merely an associated but unrelated disease. This applies in particular to joint complications, since surgery can be virtually guaranteed to cure 'colitic' arthritis but has no effect upon rheumatoid or osteoarthritis. Next it is important to stress that limited surgery such as sub-total colectomy or ileostomy alone may fail to bring about a resolution even of true systemic complications. Finally it is to be noted that there are two systemic complications of ulcerative colitis which do not appear to respond to radical surgery, namely ankylosing spondylitis and cirrhosis of the liver (Fernandez-Herlihy, 1959; Daly & Brooke, 1967) . Physical retardation. In young children or adolescents the possibility of physical retardation due to continuing colitis may be an additional reason for recommending surgery. Whilst it is unpleasant to advise an operation involving an ileostomy for a young girl or boy, it is even more distressing to see such patients, treated along conservative lines, developing into half-children half-adults. Our own experience is that surgery is often required in this situation, and not infrequently results may be gratifying in the extreme. Fortunately Our present policy is therefore, to recommend strongly to all patients who at any stage of their illness develop total colitis that they should submit to elective proctocolectomy and ileostomy.
Elderly patients. Elderly patients pose a special problem in the management of ulcerative colitis. Naturally the mortality after operation, even after elective proctocolectomy, is considerably higher in the elderly patient. Nevertheless, Figure 1 clearly shows that in elderly patients, particularly those with total involvement, the risks of conservatively managed ulcerative colitis are so enormous that even the increased hazards of surgical treatment represent a preferable alternative.
Our policy for such elderly patients therefore is to recommend elective proctocolectomy and ileostomy as soon as convenient if total colitis develops. Occasionally, there may be exceptions to this general rule, as in two of our own patients, one who is blind, and one who has Parkinson's disease. Neither of these patients could easily manage an ileostomy; but in the absence of such coincident disease, it would be a grave mistake to refrain from radical surgery purely on account of the patient's age.
